Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Post-Translational Modifications in Regulation of NLRP3 Inflammasome Activation
Jing Xia, Songhong Jiang, Shiqi Dong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6126-6126
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Tau induces inflammasome activation and microgliosis through acetylating NLRP3
Lun Zhang, Yongkang Gai, Yushuang Liu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 9
Targeting inflammasomes and pyroptosis in retinal diseases—molecular mechanisms and future perspectives
Yimeng Sun, Fan Li, Yunfei Liu, et al.
Progress in Retinal and Eye Research (2024) Vol. 101, pp. 101263-101263
Open Access | Times Cited: 9
NLRP3 Inflammasomes: Dual Function in Infectious Diseases
Yanbo Li, Rui Qiang, Zheng-Min Cao, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 4, pp. 407-417
Closed Access | Times Cited: 6
The cellular and molecular targets of natural products against metabolic disorders: a translational approach to reach the bedside
Xiaofei Shen, Hongling Yang, Yang Yang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 5
Targeting the NLRP3 inflammasome as a novel therapeutic target for osteoarthritis
Varnita Karmakar, Mayukh Chain, Ankit Majie, et al.
Inflammopharmacology (2025)
Closed Access
Inflammasomes in Alzheimer’s Progression: Nrf2 as a Preventive Target
Rubén López-Hernández, María Magdalena de la Torre-Álamo, Borja García‐Bueno, et al.
Antioxidants (2025) Vol. 14, Iss. 2, pp. 121-121
Open Access
A review on NLRP3 inflammasome modulation by animal venom proteins/peptides: mechanisms and therapeutic insights
Akshad Balde, Soottawat Benjakul, Rasool Abdul Nazeer
Inflammopharmacology (2025)
Closed Access
Macrophage pyroptosis and its crucial role in ALI/ARDS
Yuju Cai, Luorui Shang, Fangyuan Zhou, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
UFMylation of NLRP3 Prevents Its Autophagic Degradation and Facilitates Inflammasome Activation
Jiongjie Jing, Fan Yang, Ke Wang, et al.
Advanced Science (2025)
Open Access
Updating on the Dual Role of Salivary Gland Epithelial Cell (SGEC) in Sjögren’s Disease
Wen Zhu, Yun Lu, Yifan Zhu, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3039-3053
Open Access
Mechanisms and Therapeutic Strategies for NLRP3 Degradation via Post-Translational Modifications in Ubiquitin-proteasome and Autophagy Lysosomal Pathway
Kaiyue Su, Minghai Tang, Jie Wu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117476-117476
Closed Access
Ubiquitin Ligases in Control: Regulating NLRP3 Inflammasome Activation
Swarna Beesetti
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
The LTB4-BLT1 axis attenuates influenza-induced lung inflammation by suppressing NLRP3 activation
Wei Cheng, Yitian Xu, Ying Zheng, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
NLRP3 as a therapeutic target in cyclophosphamide-associated toxicities
Prathap Srirangan, Mukul Shyam, R Vidya, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
P2Y6 Receptor Activation Aggravates NLRP3-dependent Microglial Pyroptosis via Downregulation of the PI3K/AKT Pathway in a Mouse Model of Intracerebral Hemorrhage
Yulong Li, Huiru Tu, Shengfan Zhang, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 7, pp. 4259-4277
Closed Access | Times Cited: 12
Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities
Miguel Á. Ortega, Diego De León-Oliva, Cielo García‐Montero, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Unraveling the role of NLRP3 inflammasome in allergic inflammation: implications for novel therapies
Hui-Fei Lu, Yi-Chi Zhou, Tianyong Hu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Protective effects of pioglitazone in renal ischemia–reperfusion injury (RIRI): focus on oxidative stress and inflammation
Maryam Golmohammadi, Mehraveh Sadeghi Ivraghi, Ekhlas Khammas Hasan, et al.
Clinical and Experimental Nephrology (2024) Vol. 28, Iss. 10, pp. 955-968
Closed Access | Times Cited: 3
Genetic and epigenetic regulation of inflammasomes: role in atherosclerosis
Mustafa Yalcınkaya, Alan R. Tall
Atherosclerosis (2024) Vol. 396, pp. 118541-118541
Closed Access | Times Cited: 3
Recent advances in the treatment of gout with NLRP3 inflammasome inhibitors
Ye Tian, Xiaofang He, Ruping Li, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117874-117874
Closed Access | Times Cited: 3
Regulation of NLRPs by reactive oxygen species: A story of crosstalk
Bjoern Ziehr, Justin A. MacDonald
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 8, pp. 119823-119823
Open Access | Times Cited: 3
Calenduloside E Ameliorates Inflammatory Responses in Adipose Tissue via Sirtuin 2-NLRP3 Inflammasome Axis
Aini Yuan, Jing Liu, Jianan Guo, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 38, pp. 20959-20973
Closed Access | Times Cited: 3
Redox regulation of the NLRP3-mediated inflammation and pyroptosis
N. Yu. Rusetskaya, N.Yu. Loginova, E.P. Pokrovskaya, et al.
Biomeditsinskaya Khimiya (2023) Vol. 69, Iss. 6, pp. 333-352
Open Access | Times Cited: 8
The Impact of NLRP3 Inflammasome on Osteoblasts and Osteogenic Differentiation: A Literature Review
Ziyuan Yang, Jiaan Xu, Ting Kang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 2639-2653
Open Access | Times Cited: 2
The antidepressant effect of Shexiang Baoxin Pills on myocardial infarction rats with depression may be achieved through the inhibition of the NLRP3 inflammasome pathway
Y.L. Wang, Yuwen Chen, Bingqing Li, et al.
Brain and Behavior (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top